| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | 0.069 | 0.07 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.07 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.07 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.057 | 0.07 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.062 | 0.07 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | -0.057 | 0.08 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.08 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.066 | 0.08 |